drugset / Trial / NCT00103818
An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of MK0928 for insomnia (a sleep disorder).
Timeline
- Start
- 2005-02
- Primary completion
- —
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gaboxadol | Small molecule | 10 mg | — |
| Subject | gaboxadol | Small molecule | 15 mg | — |